Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

From left to right: Prof Chuxia Deng, Chair Professor and Dean of the Faculty of Health Sciences; Prof Chen Xin, Distinguished Professor and Director of the Institute of Chinese Medical Sciences; Prof ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Recent studies show how dietary choices may affect a person's risk of cancer, particularly colorectal cancer, and cancer of ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...

Researchers from National Chung Cheng University (CCU) and National Cheng Kung University (NCKU) have identified a previously ...